Open to all scientists researching new therapeutics in Cambridge and the local area

The purpose of the CamNTF forum is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance.

CamNTF was founded in 2015 by Dr David Rees (Astex Pharmaceuticals, CSO) in collaboration with Professor Sir Tom Blundell (University of Cambridge, Sir William Dunn Professor of Biochemistry) and Professor Patrick Maxwell (University of Cambridge, Regius Professor of Physic, Director Cambridge University Health Partners).

The forum was made possible by key scientific sponsors: Professor Michael Wakelam (Babraham Institute, Director), Professor Ewan Birney (EMBL-EBI, Associate Director), Dr Mene Pangalos (AstraZeneca, R&D Director) and Professor Ian Wilkinson (University of Cambridge, Professor of Therapeutics; Director of CUHP’s Office for Translational Research).


The next CamNTF meeting will be hosted by Cambridge Enterprise on Wednesday 30th of October 2019

Event registration -


The first CamNTF meeting of 2020 will be a special Artificial Intelligence seminar hosted by Cambridge University on Wednesday 22nd of January 2020.

Confirmed speakers - Andrew Senior (research scientist at Google DeepMind), Kate Hilyard (COO at healx), Carl Poelking (SI Post-doc at Astex)

More information to follow

Six meeting a year are organised, around Cambridge, hosted by various organisations and covering a wide range of topics all related to new therapeutics.